1.00
        
        
          0.50
        
        
          0.25
        
        
          0
        
        
          0.75
        
        
          200
        
        
          100
        
        
          50
        
        
          0
        
        
          150
        
        
          300
        
        
          250
        
        
          350
        
        
          Days from randomization
        
        
          Survival distribution function
        
        
          Placebo N=255
        
        
          Regorafenib N=505
        
        
          Regorafenib
        
        
          Placebo
        
        
          Median         1.9 mos           1.7 mos
        
        
          95% CI
        
        
          1.9–2.1
        
        
          1.7–1.7
        
        
          Hazard ratio: 0.49
        
        
          (95% CI: 0.42–0.58)
        
        
          1-sided p-value: <0.000001
        
        
          CORRECT: Progression-free survival
        
        
          (secondary
        
        
          endpoint)